In Vivo and in Vitro Selection of Mitogen Responsive Lymphocytes in Patients with Chronic Lymphocytic Leukemia

References

• Blomgren H., Andersson B., Johansson B. Enrichment of PHA-responsive lymphocytes in chronic lymphocytic leukaemia after removal of Ig-bearing cells. Sand. J. Haemat. 1974; 13: 352
   PubMedGoogle Scholar
• Blomgren H., Glas U., Melén B., Wasserman J. (b) Blood lymphocytes after radiation therapy of mammary carcinoma. Acta radiol. Ther. Phys. Biol. 1974; 13: 185
   PubMed Web of Science ®Google Scholar
• Brooks W. H., Netsky M. G., Normansell D. E., Horwitz D. A. Depressed cellmediated immunity in patients with primary intracranial tumors. J. exp. Med. 1972; 136: 1631
   PubMed Web of Science ®Google Scholar
• Catovsky D., Trpp E., Hoffbrand A. V. Response to phytohaemagglutinin and poke weed mitogen in chronic lymphocytic leukemia. Lancet 1972; 1: 794
   Google Scholar
• Cghnen G., Douglas S. D., König E., Brittinger G. In vitro lymphocyte response to phytohaemagglutinin and poke weed mitogen in Hodgkin's disease. Cancer 1973; 31: 6
   PubMed Web of Science ®Google Scholar
• Ducos J., Miqueres J., Colombies P., Kessons A., Poujoulet N. Lymphocyte response to PHA in patients with lung cancer. Lancet 1970; 1: 1111
   PubMed Web of Science ®Google Scholar
• Eskeland T., Klein E., Inoue M., Johansson B. Characterization of immunoglobulin structures from the surface of chronic lymphocytic leukemia cells. J. exp. Med. 1971; 134: 265
   PubMed Web of Science ®Google Scholar
• Gery I., Gershon R. K., Waksman B. H. Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J. exp. Med. 1972; 136: 128
   PubMed Web of Science ®Google Scholar
• Greaves M., Janossy G., Doenhoff M. Selective triggering of human T- and B-lymphocytes in vitro by polyclonal mitogens. J. exp. Med. 1974; 140: 1
   PubMed Web of Science ®Google Scholar
• Hann T., Takita H. Immunological impairment in bronchogenic carcinoma: A study of lymphocyte response to phyfohaemagglutinin. Cancer (N.Y.) 1972; 30: 616
   PubMed Web of Science ®Google Scholar
• Havemann K., Rubin A. D. The delayed response of chronic lymphocytic lymphocytes to phytohaemagglutinin. Proc. Soc. exp. Biol. (N.Y.) 1968; 127: 688
   Web of Science ®Google Scholar
• Johansson B., Klein E. Cell surface localized IgM-kappa immunoglobulin reactivity in a case of chronic lymphocytic leukemia. Clin. exp. Immunol. 1970; 6: 421
   PubMed Web of Science ®Google Scholar
• Jondal M. (a) Surface markers on human B- and T-lymphocytes. IV. Distribution of surface markers on resting and blast transformed lymphocytes. Sand. J. Immunol. 1974; 3: 739
   PubMed Web of Science ®Google Scholar
• Surface markers on human B- and T-lymphocytes. V. Characterization of thelympho-proliferative response to three different lectins and allogeneic lymphocytes by surface markers. Scand. J. Immunol. 1974; 6: 749
   Google Scholar
• Jondal Holm M. G., Wigzell H. Surface markers on human T- and B-lymphocytes. J. exp. Med. 1972; 136: 207
   PubMed Web of Science ®Google Scholar
• Klein E., Eskeland T., Inoue M., Strom R., Johansson B. Surface immunoglobulinmoieties on lymphoid cells. Exp. Cell Res. 1979; 62: 113
   Google Scholar
• Konig E., Cohnen G., Brittinger G., Douglas S. D. Response to phytohaemagglutinin and poke weed mitogen in chronic lymphocytic leukemia. Lancet 1972; 1: 795
   Google Scholar
• Oppenheim J. J., Leventhal B. G., Hersh E. M. The transformation of column-purified lymphocytes with non-specific and specific antigenic stimuli. J. Immunol. 1968; 101: 262
   PubMed Web of Science ®Google Scholar
• Phillips B., Roitt I. M. Evidence for transformation of human B-lymphocytes by PHA. Nature New Biology 1973; 241: 254
   PubMedGoogle Scholar
• Phillips B. The mitogenic response of human B-lymphocytes to phytohaemagglutinin. Clin. exp. Immunol. 1974; 16: 383
   PubMed Web of Science ®Google Scholar
• Roitt I. M., Greaves M. F., Torriglanti G., Brostoff J., Playfair J. H. The cellular basis of immunological responses. Lancet 1969; 2: 367
   PubMed Web of Science ®Google Scholar
• Quaglino D., Cowling D. C. Cytochemical studies on cells from chronic lymphocytic leukemia and lymphosarcoma cultured with phytohaemagglutinin. Brit. J. Haemat. 1964; 10: 358
   PubMed Web of Science ®Google Scholar
• Schweitzer M., MeIIef C. J. M., Eisvogel V. P. The nature of the transforming lymphocyte in chronic lymphocytic leukemia. Europ. J. Immunol. 1973; 3: 121
   Web of Science ®Google Scholar
• Smith M. A., Evans J., Steel C. M. Age-related variation in proportion of circulating T-cells. Lancet 1974; 2: 922
   PubMed Web of Science ®Google Scholar
• Thomson A. E. R., Robinson M. A., Whetherley-Mein G. Heterogeneity of lymphocytes in chronic lymphocytic leukemia. Lancet 1966; 2: 200
   PubMed Web of Science ®Google Scholar
• Trubowitz S., Masek B., Del Rosario A. Lymphocyte response to phytohaemagglutinin in Hodgkin's disease, lymphatic leukemia and lymphosarcoma. Cancer 1966; 19: 2019
   PubMed Web of Science ®Google Scholar
• Watkins S. M. The effects of surgery on lymphocyte transformation in patients with cancer. Clin. exp. Immunol. 1973; 14: 69
   PubMed Web of Science ®Google Scholar
• Whittaker M. G., Rees K., Clark C. G. Reduced lymphocyte transformation in breast cancer. Lancet 1970; 1: 892
   PubMed Web of Science ®Google Scholar
• Wybran J., Chantler S., Fudenberg H. H. Isolation of normal T-cells in chronic lymphatic leukemia. Lancet 1973; 1: 126
   PubMed Web of Science ®Google Scholar
• Zucker R. M., Cassen B. Effect of chemotherapy with cyclophosphamide on the buoyant density separation and volume distribution of lymphocytes in chronic lymphocytic leukemia and lymphosarcoma. J. nat. Cancer Inst. 1974; 52: 1691
   PubMedGoogle Scholar